Related Experiment Videos
Childhood pemphigus
1Department of Pediatrics, Chulalongkorn University, Bangkok, Thailand.
International Journal of Dermatology
|March 5, 1999
Summary
Childhood pemphigus, a rare autoimmune blistering disease, shows a good prognosis in children. Long-term monitoring is crucial for managing disease flares and drug side effects.
Area of Science:
- Dermatology
- Autoimmune diseases
- Pediatric dermatology
Background:
- Pemphigus is a rare autoimmune blistering disease affecting the skin and mucous membranes.
- Childhood pemphigus is exceptionally rare, with limited published cases, particularly pemphigus vegetans.
Observation:
- This report details five pediatric cases of pemphigus: three with pemphigus vulgaris, one with pemphigus vegetans, and one with pemphigus foliaceus.
- The pemphigus vegetans case is notable as only one other juvenile case exists in medical literature.
Findings:
- Patients with pemphigus vulgaris, pemphigus vegetans, and pemphigus foliaceus were treated with various combinations of oral corticosteroids, azathioprine, intralesional corticosteroids, and methotrexate.
- Follow-up over 1-4 years indicated a generally good prognosis for childhood pemphigus.
- Treatment strategies focused on achieving a steroid-sparing effect with immunosuppressive agents.
Implications:
- The favorable prognosis suggests effective management strategies are available for childhood pemphigus.
- Long-term surveillance is essential to monitor for disease recurrence and potential adverse effects of immunosuppressive therapies.
- Further research into long-term outcomes and optimal treatment protocols for pediatric pemphigus is warranted.